2-(tert-butoxycarbonylaminooxy)-2-methylpropionaldehyde | 953773-64-3

• 分子结构分类: 有机化合物 - 有机氮化合物
• 英文名称: 2-(tert-butoxycarbonylaminooxy)-2-methylpropionaldehyde
• 英文别名: 2-(tert-butyl-N-hydroxycarbamoyl)-isobutyraldehyde；tert-butyl N-(2-methyl-1-oxopropan-2-yl)oxycarbamate
• CAS: 953773-64-3
• 化学式: C₉H₁₇NO₄
• 分子量: 203.238
• InChiKey: YBHVQDLEPAAOMJ-UHFFFAOYSA-N

物化性质

• 密度：
  1.052±0.06 g/cm3(Predicted)

计算性质

• 辛醇/水分配系数(LogP)：
  1.1
• 重原子数：
  14
• 可旋转键数：
  5
• 环数：
  0.0
• sp3杂化的碳原子比例：
  0.78
• 拓扑面积：
  64.6
• 氢给体数：
  1
• 氢受体数：
  4

反应信息

• 作为反应物：
  描述：

  2-(tert-butoxycarbonylaminooxy)-2-methylpropionaldehyde 在 三乙胺 作用下， 以 正己烷 、 二氯甲烷 为溶剂， 反应 12.0h， 生成 ethyl 4-methyl-4-[N-(tert-butoxycarbonyl)-N-(benzoyl)aminooxy]-2-penteneoate
  参考文献：
  名称：

  Preparation of Unsymmetrically Labeled Hydroperoxides. A Hydroxamate Ester−Nitrosation Approach

  摘要：

  Reaction of O-tertiary alkyl arylhydroxamate esters with nitrosyl chloride gives O-tertiary alkyl aryl peresters that can be hydrolyzed to the hydroperoxide. If the hydroxamate ester carbonyl oxygen or nitrosyl chloride is labeled with O-18, the label appears in the product hydroperoxide's terminal oxygen. This strategy, which derives from the pioneering work of Koenig, permits the preparation of a variety of(2-O-18) hydroperoxides, including tertiary alkyl and cumyl hydroperoxides. tert-Butyl alpha-hydroperoxyisobutyrate, 27, prepared in this way with an O-18 label in the terminal oxygen, serves as a useful precursor for the preparation of other unsymmetrically labeled peroxides and hydroperoxides. Hydroperoxide 27 is protected as a perketal with 2-methoxypropene, and a six-step sequence involving Dibal-H reduction, oxidation (PDC), and Wittig chemistry provides the allylic hydroperoxide 12 that is used in mechanistic studies. Hydroxamate esters that give peresters prone to undergo the Criegee rearrangement upon reaction with NOCl do not give useful yields of product hydroperoxides in the transformation and one hydroxamate ester 17 that reacts via an allylalkoxyl radical gives epoxides 20a and 20b as the major isolable products of reaction.

  DOI：

  10.1021/jo980654e
• 作为产物：
  描述：

  methyl 2-(((tert-butoxycarbonyl)amino)oxy)-2-methylpropanoate 在 二异丁基氢化铝 、 水 、 Rochelle's salt 作用下， 以 二氯甲烷 、 甲醇 、 乙醚 为溶剂， 反应 4.0h， 以71%的产率得到2-(tert-butoxycarbonylaminooxy)-2-methylpropionaldehyde
  参考文献：
  名称：

  AMINO DERIVATIVES OF ANDROSTANES AND ANDROSTENES AS MEDICAMENTS FOR CARDIOVASCULAR DISORDERS

  摘要：

  化合物的化学式（I），其中：所述基团如描述中所定义，可用于制备用于治疗心血管疾病，特别是心力衰竭和高血压的药物。这些化合物是Na+，K+-ATP酶活性的抑制剂。所述化合物用于制备一种药物，用于治疗由内源性欧巴因的高血压效应引起的疾病，例如在常染色体显性多囊肾病（ADPKD）中肾功能衰竭进展、妊娠期高血压和蛋白尿以及具有adducin多态性的患者中的肾功能衰竭进展。

  公开号：

  US20110053902A1

文献信息

• Novel Analogues of Istaroxime, a Potent Inhibitor of Na⁺,K⁺-ATPase: Synthesis and Structure−Activity Relationship
  作者：Mauro Gobbini、Silvia Armaroli、Leonardo Banfi、Alessandra Benicchio、Giulio Carzana、Giorgio Fedrizzi、Patrizia Ferrari、Giuseppe Giacalone、Michele Giubileo、Giuseppe Marazzi、Rosella Micheletti、Barbara Moro、Marco Pozzi、Piero Enrico Scotti、Marco Torri、Alberto Cerri

  DOI：10.1021/jm800257s

  日期：2008.8.1

  We report the synthesis and biological properties of novel inhibitors of the Na(+),K(+)-ATPase as positive inotropic compounds. Following our previously described model from which Istaroxime was generated, the 5alpha,14alpha-androstane skeleton was used as a scaffold to study the space around the basic chain of our lead compound. Some compounds demonstrated higher potencies than Istaroxime on the receptor

  我们报告Na（+），K（+）-ATPase作为正性肌力化合物的新型抑制剂的合成和生物学特性。遵循我们先前描述的生成Istaroxime的模型后，将5alpha，14alpha-雄甾烷骨架用作支架来研究我们先导化合物的基本链周围的空间。一些化合物在受体上显示出比四氢呋喃肟更高的效价，（E）-3-[（R）-3-吡咯烷基]肟衍生物15最有效。为进一步证实我们的模型，肟的E异构体比Z形式更有效。在豚鼠模型中测试的化合物诱导了正性肌力作用，这与Na（+），K（+）-ATPase的体外抑制能力有关。发现所有受测化合物产生的心律失常性均低于地高辛，
• WO2007/118832
  申请人：——

  公开号：——

  公开（公告）日：——
• AMINO DERIVATIVES OF ANDROSTANES AND ANDROSTENES AS MEDICAMENTS FOR CARDIOVASCULAR DISORDERS
  申请人：Cerri Alberto

  公开号：US20110053902A1

  公开（公告）日：2011-03-03

  Compounds of formula (I) wherein: the groups are as defined in the description, are useful for the preparation of medicaments for the treatment of cardiovascular disorders, in particular heart failure and hypertension. The compounds are inhibitors of the enzymatic activity of the Na + , K + -ATPase. Said compounds are used for the preparation of a medicament for the treatment of a disease caused by the hypertensive effects of endogenous ouabain, such as renal failure progression in autosomal dominant polycystic renal disease (ADPKD), preeclamptic hypertension and proteinuria and renal failure progression in patients with adducin polymorphisms.

  化合物的化学式（I），其中：所述基团如描述中所定义，可用于制备用于治疗心血管疾病，特别是心力衰竭和高血压的药物。这些化合物是Na+，K+-ATP酶活性的抑制剂。所述化合物用于制备一种药物，用于治疗由内源性欧巴因的高血压效应引起的疾病，例如在常染色体显性多囊肾病（ADPKD）中肾功能衰竭进展、妊娠期高血压和蛋白尿以及具有adducin多态性的患者中的肾功能衰竭进展。
• Preparation of Unsymmetrically Labeled Hydroperoxides. A Hydroxamate Ester−Nitrosation Approach
  作者：Ned. A. Porter、Sarah E. Caldwell、Jennifer R. Lowe

  DOI：10.1021/jo980654e

  日期：1998.8.1

  Reaction of O-tertiary alkyl arylhydroxamate esters with nitrosyl chloride gives O-tertiary alkyl aryl peresters that can be hydrolyzed to the hydroperoxide. If the hydroxamate ester carbonyl oxygen or nitrosyl chloride is labeled with O-18, the label appears in the product hydroperoxide's terminal oxygen. This strategy, which derives from the pioneering work of Koenig, permits the preparation of a variety of(2-O-18) hydroperoxides, including tertiary alkyl and cumyl hydroperoxides. tert-Butyl alpha-hydroperoxyisobutyrate, 27, prepared in this way with an O-18 label in the terminal oxygen, serves as a useful precursor for the preparation of other unsymmetrically labeled peroxides and hydroperoxides. Hydroperoxide 27 is protected as a perketal with 2-methoxypropene, and a six-step sequence involving Dibal-H reduction, oxidation (PDC), and Wittig chemistry provides the allylic hydroperoxide 12 that is used in mechanistic studies. Hydroxamate esters that give peresters prone to undergo the Criegee rearrangement upon reaction with NOCl do not give useful yields of product hydroperoxides in the transformation and one hydroxamate ester 17 that reacts via an allylalkoxyl radical gives epoxides 20a and 20b as the major isolable products of reaction.